A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Recruiting · NCT07230483 · Registry updated 2025-11-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 2 | 2025-11-17 | NCT07230483 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Keymed Biosciences Co.Ltd | 28 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | 44 |